12 06, 2024 Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults Neal Evan Caminsky2024-06-12T14:42:37-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 People with Human Immunodeficiency Virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 vaccination and strong third dose responses Neal Evan Caminsky2024-06-12T12:21:42-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination Neal Evan Caminsky2024-06-12T11:32:15-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 #BeadAndThrive: How social media can support research as an iterative process Neal Evan Caminsky2024-06-12T11:18:55-04:00June 12, 2024|Funded Research Results, Pillar 7|
12 06, 2024 Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy Neal Evan Caminsky2024-06-13T10:23:35-04:00June 12, 2024|Funded Research Results, Pillar 1|
11 06, 2024 SARS-CoV-2 live virus neutralization after four COVID-19 doses in people with HIV receiving immunosuppressive antiretroviral therapy Neal Evan Caminsky2024-06-11T12:21:48-04:00June 11, 2024|Funded Research Results, Pillar 1|
3 06, 2024 Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis Neal Evan Caminsky2024-06-03T09:48:41-04:00June 3, 2024|Funded Research Results, Pillar 6|
23 05, 2024 The RNA interference effector protein Argonaute 2 functions as a restriction factor against SARS-CoV-2 Neal Evan Caminsky2024-05-23T08:58:58-04:00May 23, 2024|Funded Research Results, Pillar 4|
22 05, 2024 The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology Neal Evan Caminsky2024-05-22T14:52:11-04:00May 22, 2024|Funded Research Results, Pillar 6|
22 05, 2024 Estimating SARS-CoV-2 seroprevalence in Canadian blood donors, April 2020 to March 2021: improving accuracy with multiple assays Neal Evan Caminsky2024-05-22T13:39:08-04:00May 22, 2024|Funded Research Results, Pillar 4|